| Literature DB >> 32722270 |
Katarzyna Gaweł-Bęben1, Marcelina Strzępek-Gomółka1, Marcin Czop2, Zuriyadda Sakipova3, Kazimierz Głowniak1, Wirginia Kukula-Koch4.
Abstract
Studies on hydroglycolic (HG) extracts of Achillea biebersteinii (AB)-a less investigated representative of the genus-were performed to determine their potential for cosmetic applications compared to the well-known Achillea millefolium (AM). Three types of water:polyethylene glycol extracts (1:1, 4:1, 6:1 v/v) were obtained from both species and analyzed for their composition by high performance liquid chromatography coupled with mass spectrometry (HPLC-ESI-Q-TOF-MS) and assayed for their biological activities. The study led to the identification of 11 metabolites from different natural product classes with the highest share corresponding to 5-caffeoylquinic acid, axillarin, coumaroylquinic acid isomers and 3-caffeoylquinic acid. The highest antiradical capacity in DPPH and ABTS scavenging assays was shown for HG 4:1 of AB and AM extracts. HG 1:1 extracts from both species inhibited monophenolase and diphenolase activity of tyrosinase, whereas AB HG 4:1 extract showed significant monophenolase inhibition. The highest sun protection factor (SPF) was determined for AM HG 4:1 extract, equal to 14.04 ± 0.17. The AB extracts were cytotoxic for both human keratinocytes HaCaT and A375 melanoma, however HG 1:1 and 4:1 extracts were more cytotoxic for cancer than for noncancerous cells. In conclusion, AB HG 1:1 and 4:1 extracts display significant potential as active cosmetic ingredients.Entities:
Keywords: Achillea biebersteinii; Achillea millefolium; Asteraceae; ESI-mass spectrometry; melanoma; sun protection factor; tyrosinase
Year: 2020 PMID: 32722270 PMCID: PMC7436264 DOI: 10.3390/molecules25153368
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.411
The tentatively identified compounds in Achillea biebersteinii extracts.
| Ionization Mode | Rt [min] | Molecular Formula | Delta [ppm] | DBE | Tentative Compound | MS/MS Fragments | Ref. | AB | AB | AB | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| [M−H]− | 4.2 | C7H12O6 | 191.0573 | 191.0561 | −6.19 | 2 | Quinic acid | 129, 101 | [ | + | + | - |
| [M−H]− | 8.5 | C16H18O9 | 353.0917 | 353.0878 | −11 | 8 | 3-caffeoylquinic acid | 191, 179 | [ | + | + | - |
| [M−H]− | 10.6 | C16H18O9 | 353.0914 | 353.0878 | −10.15 | 8 | 5-caffeoylquinic acid | 191, 179 | [ | + | + | - |
| [M−H]− | 11.4 | C16H18O9 | 353.0916 | 353.0878 | −10.72 | 8 | 4-caffeoylquinic acid | 191 | [ | + | - | - |
| [M−H]− | 11.5 | C9H8O4 | 179.035 | 179.035 | −0.1 | 6 | Caffeic acid | 135 | [ | + | - | + |
| [M−H]− | 11.7 | C16H18O8 | 337.0918 | 337.0929 | 3.23 | 8 | Coumaroyl-quinic acid isomers | 191,173 | [ | + | - | - |
| [M−H]− | 12.6 | C16H18O8 | 337.0964 | 337.0929 | −10.67 | 8 | Coumaroyl-quinic acid isomers | 191 | [ | + | + | - |
| [M−H]− | 14.8 | C25H24O12 | 515.1195 | 515.1195 | 0 | 14 | Cynarin | 353, 191, 179 | [ | + | + | + |
| [M−H]− | 17.5 | C15H10O6 | 285.0407 | 285.0405 | −0.83 | 11 | Kaempferol | 133 | [ | + | + | + |
| [M−H]− | 18.2 | C17H14O8 | 345.0604 | 345.0616 | 3.44 | 11 | Axillarin | 330, 315 | [ | + | + | + |
| [M−H]− | 20.4 | C17H1407 | 329.065 | 329.0667 | 5.08 | 11 | 3,8-Dimethylherbacetin | 314, 299 | [ | + | + | - |
| [M−H]− | 20.6 | C18H16O8 | 359.076 | 359.0772 | 3.45 | 11 | Jaceidin | 329, 344 | [ | + | + | + |
Rt—retention time, Delta—difference between experimental and calculated mass (mmu), DBE-double bond equivalent, Ref—references, + detected, - not detected, AM—Achillea millefolium, AB—Achillea biebersteinii, HG—hydroglycolic extract.
Tentatively identified compounds in Achillea millefolium extracts.
| Ionization Mode | Rt [min] | Molecular Formula | Delta [ppm] | DBE | Tentative Compound | MS/MS | Ref. | AM | AM | AM | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| [M−H]− | 3.9 | C7H12O6 | 191.0568 | 191.0561 | −3.58 | 2 | Quinic acid | 129, 101 | [ | + | + | + |
| [M−H]− | 8.4 | C16H18O9 | 353.091 | 353.0878 | −9.02 | 8 | 3-caffeoylquinic acid | 191, 179 | [ | + | - | - |
| [M−H]− | 10.3 | C16H18O9 | 353.0905 | 353.0878 | −7.61 | 8 | 5-caffeoylquinic acid | 191, 179 | [ | + | + | - |
| [M−H]− | 11.3 | C16H18O9 | 353.0904 | 353.0878 | −7.33 | 8 | 4-caffeoylquinic acid | 191, 179 | [ | + | - | - |
| [M−H]− | 11.7 | C16H18O8 | 337.0958 | 337.0929 | −8.6 | 8 | Coumaroyl-quinic acid isomers | 191 | [ | + | - | - |
| [M−H]− | 12.56 | C16H18O8 | 337.0958 | 337.0929 | −8.6 | 8 | Coumaroyl-quinic acid isomers | 191 | [ | + | - | - |
| [M−H]− | 14.8 | C25H24O12 | 515.1243 | 515.1195 | −9.3 | 14 | Cynarin | 353, 179 | [ | + | - | - |
| [M−H]− | 17.5 | C15H10O6 | 285.0386 | 285.0405 | 6.51 | 11 | Kaempferol | 193, 127 | [ | + | + | + |
| [M−H]− | 20.6 | C18H16O8 | 359.0769 | 359.0772 | 0.95 | 11 | Jaceidin | 329, 344 | [ | + | - | - |
Rt—retention time, Delta—difference between experimental and calculated mass (mmu), DBE-double bond equivalent, Ref—references, + detected, - not detected, AM—Achillea millefolium, AB—Achillea biebersteinii, HG—hydroglycolic extract.
Quantitative analysis of the selected identified compounds in A. millefolium and A. biebersteinii hydroglycolic extracts *; each value represents mean content of the compound in mg per 100 g of dried powder ± SD (n = 3); ND—not detected.
| Compound/Extract |
|
| ||||
|---|---|---|---|---|---|---|
| HG 1:1 | HG 4:1 | HG 6:1 | HG 1:1 | HG 4:1 | HG 6:1 | |
| Cynarin | 1.215 ± 0.008 | 0.076 ± 0.004 a | 0.078 ± 0.000 a | 0.119 ± 0.002 | ND | ND |
| 3-caffeoylquinic acid | 1.922 ± 0.089 | 0.524 ± 0.011 b | 0.451 ± 0.039 b | 0.595 ± 0.068 b | ND | ND |
| 5-caffeoylquinic acid | 3.181 ± 0.139 | 1.435 ± 0.033 | 1.102 ± 0.093 c | 0.993 ± 0.092 c | 0.036 ± 0.004 | ND |
| 4-caffeoylquinic acid | 1.207 ± 0.021 | 0.209 ± 0.024 d | 0.193 ± 0.005 d | 0.466 ± 0.013 | ND | ND |
| Caffeic acid | 0.036 ± 0.003e | 0.035 ± 0.009 e | 0.037 ± 0.005 e | ND | ND | ND |
| Kaempferol | 0.784 ± 0.001 | 0.141 ± 0.003 | 0.113 ± 0.012 | 0.272 ± 0.021 | 0.065 ± 0.001 | 0.022 ± 0.001 |
| Jaceidin | 0.815 ± 0.048 | ND | 0.005 ± 0.001 f | 0.043 ± 0.008 f | ND | ND |
| Axillarin | 2.539 ± 0.265 | 0.055 ± 0.007 | ND | ND | ND | ND |
| Coumaroyl-quinic acid isomers | 0.203 ± 0.016 g | 0.129 ± 0.010 g | 0.131 ± 0.000 g | 0.734 ± 0.069 | ND | ND |
| Coumaroyl-quinic acid isomers | 0.121 ± 0.007 h | 0.106 ± 0.002 h | 0.117 ± 0.012 h | 1.733 ± 0.105 | ND | ND |
| Quinic acid | 0.684 ± 0.470 i | 0.868 ± 0.008 i,j | 0.071 ± 0.000 | 1.172 ± 0.142 i,k | 1.201 ± 0.050 i,k | 1.294 ± 0.126 j,k |
| 3,8-Dimethylherbacetin | 0.660 ± 0.025 | 0.023 ± 0.002 | ND | ND | ND | ND |
* The contents of cynarin and caffeic acid were calculated from the curve of caffeic acid, the content of kaempferol, jaceidin and axillarin was obtained from the quercetin curve, the concentration of 3-CQA, 4-CQA, 5-CQA, quinic acid and coumaroylquinic acid isomers were calculated from the chlorogenic acid curve. a–k Means in each row not sharing the same letter are significantly different at p < 0.05.
DPPH and ABTS radical scavenging activity of hydroglycolic (HG) extracts from A. millefolium and A. biebersteinii; each value represents mean ± SD (n = 3). Means in each column not sharing the same letter are significantly different at p < 0.05.
| IC50 (%) ± SD | |||
|---|---|---|---|
| DPPH Scavenging | ABTS Scavenging | ||
|
| HG 1:1 | 3.58 ± 0.96 | 0.43 ± 0.14 b,c |
| HG 4:1 | 0.68 ± 0.02 a | 0.30 ± 0.03 b | |
| HG 6:1 | 1.68 ± 0.38 a | 0.49 ± 0.14 b,c | |
|
| HG 1:1 | 0.91 ± 0.05 a | 0.72 ± 0.17 c |
| HG 4:1 | 0.68 ± 0.05 a | 0.38 ± 0.04 b | |
| HG 6:1 | 1.01 ± 0.08 a | 0.56 ± 0.05 b,c | |
|
| 0.78 ± 0.05 μg/mL | 0.46 ± 0.02 μg/mL | |
a–c Means in each column not sharing the same letter are significantly different at p < 0.05.
Figure 1Inhibitory effect of A. millefolium and A. biebersteinii extracts on the monophenolase (A) and diphenolase (B) activity of mushroom tyrosinase in comparison with 50 μg/mL kojic acid (KA); values on graphs represent mean ± SD (n = 3); * p < 0.05, ** p < 0.001, *** p < 0.0001.
In vitro sun protection factor (SPF) of hydroglycolic (HG) extracts from A. millefolium and A. biebersteinii, each value represents mean ± SD (n = 3).
| 5% | 2.5% | 1.25% | ||
|---|---|---|---|---|
|
| HG 1:1 | 12.24 ± 0.20 | 5.65 ± 0.15 b | 2.59 ± 0.21 d,f |
| HG 4:1 | 14.04 ± 0.17 | 7.15 ± 0.14 | 2.98 ± 0.18 f | |
| HG 6:1 | 9.49 ± 0.24 | 4.78 ± 0.08 | 1.90 ± 0.11 c,e | |
|
| HG 1:1 | 11.67 ± 0.30 a | 5.74 ± 0.13 b | 2.24 ± 0.06 c,d,e,f |
| HG 4:1 | 11.64 ± 0.09 a | 5.90 ± 0.14 b | 2.37 ± 0.13 c,d | |
| HG 6:1 | 8.30 ± 0.04 | 3.86 ± 0.16 | 1.85 ± 0.21 e | |
|
| 1 mg/mL | 16.79 ± 0.49 |
a–f Means in table not sharing the same letter are significantly different at p < 0.05.
Figure 2In vitro cytotoxicity of A. biebersteinii (A,C,E) and A. millefolium (B,D,F) extracts against human keratinocytes HaCaT and A375 human malignant melanoma cell lines; values on graphs represent mean ± SD (n = 3); * p < 0.05, *** p < 0.0001.
Figure 3Morphology of A375 (A) and HaCaT (B) cells treated for 48 h with tested extracts or appropriate solvents at 2.5% concentration; the cells were stained with neutral red; pictures are representative for three experiments, magnification 4×, scale bar = 100 μm.
Normalized product function used in the calculation of SPF. EE—erythremal effect spectrum, I—solar intensity spectrum; values adapted from the work of Sayre and co-workers [50].
| Wavelength (λ, nm) | EE × I (Normalized) |
|---|---|
| 290 | 0.0150 |
| 295 | 0.0817 |
| 300 | 0.2874 |
| 305 | 0.3278 |
| 310 | 0.1864 |
| 315 | 0.0839 |
| 320 | 0.0180 |
| Total | 1 |